Trailing-twelve-month (TTM) revenue is $2.37 Million with a year-over-year growth of +13.43%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $690,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $421,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-13 |
| Q1 FY2026Period ended 2026-03-31 | $493,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $770,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $2,374,000 |
Current P/S: $4,401,844 market capitalization ÷ $2,374,000 TTM revenue = 1.85x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $770000.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:05:41.421Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2022-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD |
|---|---|
| Product Sales | $1M |
$2.37M
$2.37 Million
+13.43%
vs. $2.09M a year ago (TTM)
+42.94%
5 Year compound annual growth rate
1 Year
+13.43%
3 Year
+29.81%
5 Year
+42.94%
10 Year
+23.92%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.22M | +$364,000 | +19.60% |
| 2024 | $1.86M | +$664,000 | +55.66% |
| 2023 | $1.19M | +$174,000 | +17.08% |
| 2022 | $1.02M | +$443,000 | +76.91% |
| 2021 | $576,000 | +$318,000 | +123.26% |
| 2020 |
TTM Growth
+13.43%
3-Year CAGR
+29.81%
5-Year CAGR
+42.94%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:05:41.421Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $258,000 |
| +$115,000 |
| +80.42% |
| 2019 | $143,000 | ($154,000) | (51.85%) |
| 2018 | $297,000 | +$245,000 | +471.15% |
| 2017 | $52,000 | ($266,000) | (83.65%) |
| 2016 | $318,000 | +$77,000 | +31.95% |
